First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients
Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patie...
Första patienterna utvärderas med CADScor®System i Storbritannien
Pressmeddelande Malmö, Sverige, 14 januari, 2020 Första patienterna utvärderas med CADScor®System i Storbritannien...
First patients with the CADScor®System in the UK
Press release Malmö, Sweden January 14, 2020 First patients with the CADScor®System in the UK Acarix AB (publ) (ACARIX: FN...
Acarix AB: Redeye initiates coverage of Acarix
Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system's invention of coronary artery di...
Acarix submits FDA application
Press release Malmö, Sweden 16 December, 2019 Acarix submits FDA application Acarix AB (publ) (ACARIX: FN Stockholm) today anno...
Acarix lämnar in FDA-ansökan
Pressmeddelande Malmö, Sverige, 16 december, 2019 Acarix lämnar in FDA-ansökan Acarix AB (publ) (ACARIX: FN Stockholm...
Announcement from Acarix’s extra general meeting
Press releaseMalmö August 5, 2019Announcement from Acarix's extra general meetingThe extra general meeting ("EGM") of Acarix AB ("...
Kommuniké från extra bolagsstämma i Acarix
Press releaseMalmö Augusti 16, 2019Kommuniké från extra bolagsstämma i AcarixExtra bolagsstämman i Acarix A...
CADScor®System – Significantly more effective than current practice
Press release Malmö August 5, 2019CADScor®System – Significantly more effective than current practice Acarix AB (publ) (...
CADScor®System – Betydligt effektivare än nuvarande metoder
Press release Malmö Augusti 5, 2019CADScor®System – Betydligt effektivare än nuvarande metoder Acarix AB (publ) (AC...
Kallelse till extra bolagsstämma i Acarix AB
Pressrelease 17 juli 2019Kallelse till extra bolagsstämma i Acarix ABAktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget")...
Notice of extra general meeting in Acarix AB
Press release July 17, 2019Notice of extra general meeting in Acarix ABThe shareholders of Acarix AB, reg. no. 559009-0667, (the "Compa...